B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Phase 3 - rapid repolarisation

REACTOME PATHWAY
Reactome: R-HSA-55768904 genes155 compounds

The Phase 3 - rapid repolarisation pathway (Reactome ID: R-HSA-5576890) involves 4 genes and is affected by 155 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

KCNA5KCNE1KCNH2KCNQ1

Compounds Affecting Phase 3 - rapid repolarisation

#CompoundTargets HitStudies
1Duloxetine Hydrochloride993
2Quinidine298
3vinpocetine299
4Clotrimazole296
5Flecainide297
6Thioridazine35
7Oleic Acid112
817 alpha-Hydroxyprogesterone Caproate Hydroxyprogesterone derivative that acts as287
9Nisoldipine297
10Calcimycin216
11Nortriptyline28
12dihydrorotenone13
13Astemizole Antihistamine drug now withdrawn from280
14dofetilide298
15Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent299
16Aripiprazole298
17Domperidone299
18Loratadine296
19Fluoxetine1,000
20Reserpine297
21lidoflazine278
22clofilium tosylate4
23Fluspirilene74
24Vincamine300
25Amoxapine259
26Fenofibrate297
27Lumefantrine299
28Phenoxybenzamine21
29Cinnarizine299
30Metergoline144
31Nitrendipine299
32Ondansetron299
33Perphenazine297
34Rimonabant300
35Celecoxib295
36Dibucaine299
37dilazep300
38Flunarizine Flunarizine is299
39Hydroxyzine298
40Lovastatin300
41Loxapine30
42Maprotiline299
43Vitamin K 3300
44Nebivolol297
45Nicergoline300
46Nylidrin90
47oxatomide [Supplementary Concept] structure;128
48Phentolamine300
49pirenperone22
50Promazine40

About the Phase 3 - rapid repolarisation Pathway

The Phase 3 - rapid repolarisation pathway is catalogued in Reactome (ID: R-HSA-5576890) and involves 4 genes. In the BiohacksAI corpus, 155 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include KCNA5, KCNE1, KCNH2, KCNQ1.